Literature DB >> 16375667

Mechanisms of focal adhesion kinase regulation.

Lee Ann Cohen1, Jun-Lin Guan.   

Abstract

Focal adhesion kinase (FAK) is a tyrosine kinase whose phosphorylation state and activity is tightly linked to cell adhesion to the extracellular matrix through integrin receptors. FAK's regulation by adhesion places it in a key position to be able to influence cellular events that are either dependent on cell adhesion like cell proliferation and survival, or that require modulation of cell adhesion like cell migration. FAK's involvement in cellular pathways that regulate cell growth and cell movement suggests that it may contribute to the development of cancer or other diseases. FAK's possible involvement in these pathways makes it a potential drug target. In this review we will focus on the developing view how FAK's activity and phosphorylation are regulated within the cell. Specifically, we will address the contribution of integrins and growth factor dependent pathways to FAK's activation. The role of the tyrosine kinase Src in FAK's regulation will be discussed. The contribution of various negative regulators of FAK's phosphorylation on its regulation including phosphatases and proteases will be discussed. Lastly, the emerging role of FAK's amino terminal FERM like domain in FAK's regulation will be explored. FAK's function within a cell are tightly linked to its phosphorylation state, thus understanding its normal regulation in the cell will provide important insight into drug development by highlighting novel regulatory mechanisms within FAK that potentially may be exploited.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16375667     DOI: 10.2174/156800905774932798

Source DB:  PubMed          Journal:  Curr Cancer Drug Targets        ISSN: 1568-0096            Impact factor:   3.428


  50 in total

1.  Directing integrin-linked endocytosis of recombinant AAV enhances productive FAK-dependent transduction.

Authors:  Paul M Kaminsky; Nicholas W Keiser; Ziying Yan; Diana C M Lei-Butters; John F Engelhardt
Journal:  Mol Ther       Date:  2012-01-10       Impact factor: 11.454

2.  Blood cells and endothelial barrier function.

Authors:  Stephen F Rodrigues; D Neil Granger
Journal:  Tissue Barriers       Date:  2015-04-03

Review 3.  Nonreceptor tyrosine kinases in prostate cancer.

Authors:  Yu-Ming Chang; Hsing-Jien Kung; Christopher P Evans
Journal:  Neoplasia       Date:  2007-02       Impact factor: 5.715

Review 4.  Role of the integrin alphaVbeta3 in mediating increased smooth muscle cell responsiveness to IGF-I in response to hyperglycemic stress.

Authors:  David R Clemmons; Laura A Maile; Yan Ling; J Yarber; Walker H Busby
Journal:  Growth Horm IGF Res       Date:  2007-04-06       Impact factor: 2.372

Review 5.  Focal adhesion: a focal point in current cell biology and molecular medicine.

Authors:  Chuanyue Wu
Journal:  Cell Adh Migr       Date:  2007-01-27       Impact factor: 3.405

6.  Timing is everything: Rac1 controls Net1A localization to regulate cell adhesion.

Authors:  Heather S Carr; Jeffrey A Frost
Journal:  Cell Adh Migr       Date:  2013-06-10       Impact factor: 3.405

7.  Shp2 acts downstream of SDF-1alpha/CXCR4 in guiding granule cell migration during cerebellar development.

Authors:  Kazuki Hagihara; Eric E Zhang; Yue-Hai Ke; Guofa Liu; Jan-Jan Liu; Yi Rao; Gen-Sheng Feng
Journal:  Dev Biol       Date:  2009-07-25       Impact factor: 3.582

8.  Structural basis for the autoinhibition of focal adhesion kinase.

Authors:  Daniel Lietha; Xinming Cai; Derek F J Ceccarelli; Yiqun Li; Michael D Schaller; Michael J Eck
Journal:  Cell       Date:  2007-06-15       Impact factor: 41.582

9.  Role of kinase-independent and -dependent functions of FAK in endothelial cell survival and barrier function during embryonic development.

Authors:  Xiaofeng Zhao; Xu Peng; Shaogang Sun; Ann Y J Park; Jun-Lin Guan
Journal:  J Cell Biol       Date:  2010-06-07       Impact factor: 10.539

10.  alpha- and gamma-Protocadherins negatively regulate PYK2.

Authors:  Jian Chen; Yanyan Lu; Shuxia Meng; Meng-Hsuan Han; Chengyi Lin; Xiaozhong Wang
Journal:  J Biol Chem       Date:  2008-12-01       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.